India vaccine manufacturer Bharat Biotech on Wednesday got ‘in principle’ approval from the country’s drug regulator to test nasal COVID-19 vaccine as a booster shot.
The drug regulator DCGI granted approval to Hyderabad-based Bharat Biotech for conducting late-stage trials of its nasal COVID-19 vaccine to be used as a booster shot, according to news agency ANI.
Read the latest updates in our dedicated coronavirus section.
Meanwhile, India on Wednesday reported 58,097 new COVID-19 cases, 124 deaths in last 24 hours. The government said that the country has reported 2,135 omicron cases so far.
For the latest headlines, follow our Google News channel online or via the app.
Read more: India launches drive to vaccinate children before a feared omicron surge
